Intracellular events mediating insulin-like growth factor I-induced oligodendrocyte development: modulation by cyclic AMP

J Neurochem. 2005 Nov;95(4):1091-107. doi: 10.1111/j.1471-4159.2005.03419.x.

Abstract

Insulin-like growth factor I (IGF-I) is a potent inducer of oligodendrocyte development and myelination. Although IGF-I intracellular signaling has been well described in several cell types, intracellular mechanisms for IGF-I-induced oligodendrocyte development have not been defined. By using specific inhibitors of intracellular signaling pathways, we report here that the MAPK and phosphatidylinositol 3-kinase signaling pathways are required for the full effect of IGF-I on oligodendrocyte development in primary mixed rat cerebrocortical cell cultures. The MAPK activation, but not the phosphatidylinositol 3-kinase activation, leads to phosphorylation of the cAMP response element-binding protein, which is necessary for IGF-I to induce oligodendrocyte development. cAMP, although it does not show any effect on oligodendrocyte development, has an inhibitory effect on IGF-I-induced oligodendrocyte development that is mediated by the cAMP-dependent protein kinase. Furthermore, cAMP also has an inhibitory effect on IGF-I-dependent MAPK activation. This is a cAMP-dependent protein kinase-independent effect and probably contributes to the cAMP action on IGF-I-induced oligodendrocyte development.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Blotting, Western / methods
  • Cell Differentiation / drug effects*
  • Cells, Cultured
  • Cerebellar Cortex / cytology
  • Cyclic AMP / pharmacology*
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Drug Interactions
  • Embryo, Mammalian
  • Enzyme Inhibitors / pharmacology
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Gene Expression Regulation, Developmental / drug effects*
  • Glial Fibrillary Acidic Protein / metabolism
  • Immunohistochemistry / methods
  • Insulin-Like Growth Factor I / pharmacology*
  • Intracellular Space / drug effects*
  • Models, Biological
  • Myelin Basic Protein / metabolism
  • Oligodendroglia / cytology*
  • Oligodendroglia / drug effects
  • Proto-Oncogene Proteins c-akt / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Time Factors
  • Tubulin / metabolism

Substances

  • Cyclic AMP Response Element-Binding Protein
  • Enzyme Inhibitors
  • Glial Fibrillary Acidic Protein
  • Myelin Basic Protein
  • Tubulin
  • Insulin-Like Growth Factor I
  • Cyclic AMP
  • Proto-Oncogene Proteins c-akt
  • Extracellular Signal-Regulated MAP Kinases